Comparison between CAMS IPO and Rossari Biotech IPO.
CAMS IPO is a Mainboard Bookbuilding IPO proposed to list at BSE while Rossari Biotech IPO is a Mainboard Bookbuilding proposed to list at BSE, NSE.
The total issue size of CAMS IPO is up to ₹2,243.12 Cr whereas the issue size of the Rossari Biotech IPO is up to ₹496.25 Cr. The final issue price of CAMS IPO is ₹1,230.00 per share and of Rossari Biotech IPO is ₹425.00 per share.
| CAMS IPO | Rossari Biotech IPO | |
|---|---|---|
| Face Value | ₹10 per share | ₹2 per share |
| Issue Price (Lower) | ₹1,229.00 per share | ₹423.00 per share |
| Issue Price (Upper) | ₹1,230.00 per share | ₹425.00 per share |
| Issue Price (Final) | ₹1,230.00 per share | ₹425.00 per share |
| Discount (Retail) | ₹0.00 per share | ₹0.00 per share |
| Discount (Employee) | ₹122.00 per share | |
| Market Lot Size | 12 shares | 35 shares |
| Fresh Issue Size | 0 shares | 11,76,470 shares |
| Fresh Issue Size (Amount) | up to ₹0.00 Cr | up to ₹50.00 Cr |
| OFS Issue Size | 1,82,46,600 shares | 1,05,00,000 shares |
| OFS Issue Size (Amount) | up to ₹2,243.12 Cr | up to ₹446.25 Cr |
| Issue Size Total | 1,82,46,600 shares | 1,16,76,470 shares |
| Issue Size Total (Amount) | up to ₹2,243.12 Cr | up to ₹496.25 Cr |
CAMS IPO opens on Sep 21, 2020, while Rossari Biotech IPO opens on Jul 13, 2020. The closing date of CAMS IPO and Rossari Biotech IPO is Sep 23, 2020, and Jul 15, 2020, respectively.
| CAMS IPO | Rossari Biotech IPO | |
|---|---|---|
| Anchor Bid Date | Sep 18, 2020 | Jul 10, 2020 |
| Issue Open | Sep 21, 2020 | Jul 13, 2020 |
| Issue Close | Sep 23, 2020 | Jul 15, 2020 |
| Basis Of Allotment (Tentative) | Sep 28, 2020 | Jul 20, 2020 |
| Initiation of Refunds (Tentative) | Sep 29, 2020 | Jul 21, 2020 |
| Credit of Share (Tentative) | Sep 30, 2020 | Jul 22, 2020 |
| Listing date (Tentative) | Oct 01, 2020 | Jul 23, 2020 |
| Anchor Lockin End date 1 | Oct 28, 2020 | Aug 19, 2020 |
| Anchor Lockin End date 2 | Dec 27, 2020 | Oct 18, 2020 |
CAMS IPO P/E ratio is , as compared to Rossari Biotech IPO P/E ratio of 33.81.
| CAMS IPO | Rossari Biotech IPO | |||||
|---|---|---|---|---|---|---|
| Financials | Company Financials ()
| Company Financials ()
| ||||
| Promoter Shareholding (Pre-Issue) | 43.53 | 95.06 | ||||
| Promoter Shareholding (Post-Issue) | 73 | |||||
| P/E Ratio | 33.81 | |||||
| Market Cap | ₹6000.78 Cr. | ₹2207.00 Cr. | ||||
| ROE | ||||||
| ROCE | ||||||
| Debt/Equity | ||||||
| EPS | ||||||
| RoNW |
In the CAMS IPO Retail Individual Investors (RII) are offered 63,22,435 shares while in Rossari Biotech IPO retail investors are offered 63,22,435 shares. Qualified Institutional Buyers (QIB) are offered 36,12,820 shares in CAMS IPO and 23,35,294 shares in Rossari Biotech IPO.
| CAMS IPO | Rossari Biotech IPO | |
|---|---|---|
| Anchor Investor Reservation | 54,19,230 shares | 35,02,940 shares |
| Market Maker Reservation | ||
| QIB | 36,12,820 shares | 23,35,294 shares |
| NII | 27,09,615 shares | 17,51,471 shares |
| RII | 63,22,435 shares | 40,86,765 shares |
| Employee | 1,82,500 shares | |
| Others | ||
| Total | 1,82,46,600 shares | 1,16,76,470 shares |
CAMS IPO subscribed 46.99x in total, whereas Rossari Biotech IPO subscribed 79.37x.
| CAMS IPO | Rossari Biotech IPO | |
|---|---|---|
| QIB (times) | 73.18x | 85.26x |
| NII (times) | 111.85x | 239.83x |
| Big NII (times) | ||
| Small NII (times) | ||
| RII (times) | 5.54x | 7.23x |
| Employee (times) | 1.16x | |
| Other (times) | ||
| Total (times) | 46.99x | 79.37x |
